{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:37:34Z","timestamp":1793407054336,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.humpath.2021.07.004","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T05:19:40Z","timestamp":1626758380000},"page":"82-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"116","author":[{"given":"Kwun Wah","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara A.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3845-0798","authenticated-orcid":false,"given":"Dhanpat","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Feely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6812-1816","authenticated-orcid":false,"given":"Ali","family":"Zarrinpar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Al Diffalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0538-2151","authenticated-orcid":false,"given":"Paul B.","family":"Shyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8686-4867","authenticated-orcid":false,"given":"Rondell P.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2593-8268","authenticated-orcid":false,"given":"Michael G.","family":"Drage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2526-4080","authenticated-orcid":false,"given":"Sanjay","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2021.07.004_bib1","first-page":"254","volume":"vol. 1","year":"2019"},{"key":"10.1016\/j.humpath.2021.07.004_bib2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00428-005-1241-3","article-title":"Hepatic adenocarcinoma expressing inhibin in a young patient on oral contraceptives","volume":"446","author":"Vrettou","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2021.07.004_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.humpath.2017.02.001","article-title":"Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as \"cholangioblastic variant of intrahepatic cholangiocarcinoma\"","volume":"62","author":"Braxton","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.07.004_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00428-009-0874-z","article-title":"Intrahepatic cholangiocarcinoma resembling a thyroid follicular neoplasm","volume":"456","author":"Fornelli","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2021.07.004_bib5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1665-2681(19)31427-9","article-title":"Thyroid-like cholangiocarcinoma of the liver: an unusual morphologic variant with follicular, trabecular and insular patterns","volume":"11","author":"Chable-Montero","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.humpath.2021.07.004_bib6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.2013.80","article-title":"Children's Oncology Group Liver Tumor C. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium","volume":"27","author":"Lopez-Terrada","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.07.004_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/mpo.10173","article-title":"Hepatoblastoma with cholangioblastic features ('cholangioblastic hepatoblastoma') and other liver tumors with bimodal differentiation in young patients","volume":"39","author":"Zimmermann","year":"2002","journal-title":"Med Pediatr Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2021.07.004_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00428-020-02864-y","article-title":"Primary hepatic carcinoma with inhibin positivity in a young male patient: a rare tumor previously only reported in females-case report and review of literature","volume":"478","author":"Liang","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2021.07.004_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/13651820801992641","article-title":"Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma","volume":"10","author":"Khan","year":"2008","journal-title":"HPB"},{"key":"10.1016\/j.humpath.2021.07.004_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/PAS.0000000000000343","article-title":"Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms","volume":"39","author":"Shahid","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.07.004_bib11","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/PAS.0000000000000484","article-title":"Expression of albumin mRNA in primary hepatic neoplasms and acinar cell carcinoma","volume":"39","author":"Ting","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.07.004_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1309\/8L872RPHEJRKF5JJ","article-title":"Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma","volume":"119","author":"Kakar","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2021.07.004_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1245\/s10434-014-4247-8","article-title":"The ability to diagnose intrahepatic cholangiocarcinoma definitively using novel branched DNA-enhanced albumin RNA in situ hybridization technology","volume":"23","author":"Ferrone","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2021.07.004_bib14","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/PAS.0b013e3181e5dffa","article-title":"Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms","volume":"34","author":"Yan","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.07.004_bib15","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ng.2273","article-title":"Exome sequencing of liver fluke-associated cholangiocarcinoma","volume":"44","author":"Ong","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2021.07.004_bib16","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ng.2806","article-title":"Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers","volume":"45","author":"Chan-On","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2021.07.004_bib17","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ng.2813","article-title":"Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas","volume":"45","author":"Jiao","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2021.07.004_bib18","doi-asserted-by":"crossref","first-page":"e115383","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2021.07.004_bib19","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1038\/ncomms7087","article-title":"Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma","volume":"6","author":"Sia","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2021.07.004_bib20","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.celrep.2017.06.008","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles","volume":"19","author":"Farshidfar","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.humpath.2021.07.004_bib21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Canc Discov"},{"key":"10.1016\/j.humpath.2021.07.004_bib22","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ng.3126","article-title":"Trans-ancestry mutational landscape of hepatocellular carcinoma genomes","volume":"46","author":"Totoki","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2021.07.004_bib23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2021.07.004_bib24","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2021.07.004_bib25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2021.07.004_bib26","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ng.2391","article-title":"Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma","volume":"44","author":"Huang","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2021.07.004_bib27","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/ncomms7120","article-title":"Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity","volume":"6","author":"Fujimoto","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2021.07.004_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001729","article-title":"A novel NIPBL-NACC1 Gene Fusion is Characteristic of the Cholangioblastic Variant of Intrahepatic Cholangiocarcinoma.","author":"Argani","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.07.004_bib29","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1242\/jcs.197236","article-title":"Independent mechanisms recruit the cohesin loader protein NIPBL to sites of DNA damage","volume":"130","author":"Bot","year":"2017","journal-title":"J Cell Sci"},{"key":"10.1016\/j.humpath.2021.07.004_bib30","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.humpath.2013.03.022","article-title":"Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma","volume":"44","author":"Mano","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.07.004_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.21952","article-title":"Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate","volume":"47","author":"Decaens","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2021.07.004_bib32","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1101\/gad.340305","article-title":"Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors","volume":"19","author":"Clotman","year":"2005","journal-title":"Genes Dev"},{"key":"10.1016\/j.humpath.2021.07.004_bib33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4161\/cc.5.2.2341","article-title":"Control of hepatic differentiation by activin\/TGFbeta signaling","volume":"5","author":"Clotman","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2021.07.004_bib34","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1074\/jbc.270.11.6308","article-title":"Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism","volume":"270","author":"Xu","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2021.07.004_bib35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jhep.2006.06.014","article-title":"Deregulation of the activin\/follistatin system in hepatocarcinogenesis","volume":"45","author":"Grusch","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2021.07.004_bib36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13045-017-0528-6","article-title":"Role of AP-2alpha and MAPK7 in the regulation of autocrine TGF-beta\/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma","volume":"10","author":"Zhang","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.humpath.2021.07.004_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054499","article-title":"Transforming growth factor beta neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats","volume":"8","author":"Ling","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2021.07.004_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183932","article-title":"TGF-beta signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: a study on human primary cell cultures","volume":"12","author":"Lustri","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2021.07.004_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/nrgastro.2015.209","article-title":"Liver cancer: TGF-beta and cholangiocarcinoma","volume":"13","author":"Patman","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2021.07.004_bib40","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Canc Res"},{"key":"10.1016\/j.humpath.2021.07.004_bib41","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/PAS.0b013e31826e0249","article-title":"Intrahepatic cholangiocarcinoma with predominant \"ductal plate malformation\" pattern: a new subtype","volume":"36","author":"Nakanuma","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.07.004_bib42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1365-2559.2003.01615.x","article-title":"Stages of normal and aberrant intrahepatic bile duct development in a mixed hepatoblastoma","volume":"42","author":"Libbrecht","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2021.07.004_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1093526619875228","article-title":"Hepatoblastoma and pediatric hepatocellular carcinoma: an update","volume":"23","author":"Ranganathan","year":"2020","journal-title":"Pediatr Dev Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:38:55Z","timestamp":1758645535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817721001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":43,"alternative-id":["S0046817721001258"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2021.07.004","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibin-positive hepatic carcinoma: proposal for a solid-tubulocystic variant of intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2021.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}